UK

[FtsS09F14Corrigendum]

[Information]

[Published]

[ExternalReference]: 2024-515303

[FtsReference]: 2024-016433

[FtsS09F14Corrigendum]

[NoticeCorrigendum]

[NoticeCorrigendumSub]

[Supplies]

[Section1]: [CaCe]

I.1)

[NameAddressContact]

Nottingham Trent University (NTU)
GB 277399933
50 Shakespeare Street
Nottingham
NG1 4FQ
UK
[Contactpoint]: Mark Lucas
[AddressPhone]: +44 1158488747
[AddressEmail]: mark.lucas@ntu.ac.uk
[Nutscode]:  UKF14 -  Nottingham
[Internets]:
[UrlGeneral]: https://www.ntu.ac.uk/
[UrlBuyerprofile]: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Clinical Trial Manufacturing and Distribution Services
[Fileref]:  NTU/24/2615/ML
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

[Section6]: [InfoComplement]

VI.6)

[IcarOriginalRef]

[NumberOj]: 2024/S 000-014973

[Section7]: [Changes]

VII.1)

[IcarCorrectAdd]

VII.1.2)

[IcarTextCorrected]

VII.2)

[IcarOtherInfo]

Extension of deadline from 10AM, 29/05/2024 to 10AM 07/06/2024 facilitate submission of pre-market engagement responses.